RUFY3 and RUFY4 are ARL8 effectors that promote coupling of endolysosomes to dynein-dynactin

Tal Keren‐Kaplan(AstraZeneca (Netherlands)), Juan S. Bonifacino(Eunice Kennedy Shriver National Institute of Child Health and Human Development)
Nature Communications
March 21, 2022
Cited by 75


Related Papers